Tekla Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $12.3M | Hold |
|
|||||
2023
Q1 | $11.3M | Hold |
|
|||||
2022
Q4 | $12.3M | Hold |
|
|||||
2022
Q3 | $11.7M | Sell |
|
|||||
2022
Q2 | $15.5M | Buy |
|
|||||
2022
Q1 | $8.6M | Buy |
|
|||||
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $6.47M | Sell |
|
|||||
2019
Q3 | $6.79M | Hold |
|
|||||
2019
Q2 | $7.81M | Hold |
|
|||||
2019
Q1 | $8.06M | Sell |
|
|||||
2018
Q4 | $10.4M | Buy |
|
|||||
2018
Q3 | $12.4M | Sell |
|
|||||
2018
Q2 | $23.8M | Hold |
|
|||||
2018
Q1 | $22M | Buy |
|
|||||
2017
Q4 | $19.2M | Hold |
|
|||||
2017
Q3 | $19.6M | Hold |
|
|||||
2017
Q2 | $17.5M | Hold |
|
|||||
2017
Q1 | $15.7M | Buy |
|
|||||
2016
Q4 | $10.6M | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $15.9M | Hold |
|
|||||
2016
Q1 | $15.2M | Buy |
|